SMTL ID : 6vgl.2 (3 other biounits)

JAK2 JH1 in complex with ruxolitinib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x RXT: (3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile(Non-covalent)

RXT.1: 16 residues within 4Å: Chain A: L.31, G.32, K.33, G.34, V.39, A.56, V.87, M.105, E.106, Y.107, L.108, R.156, N.157, L.159, G.169, D.170 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:V.39, A:L.159, A:L.159 Hydrogen bonds: A:E.106, A:L.108 Water bridges: A:G.111

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Davis, R.R. et al., Structural Insights into JAK2 Inhibition by Ruxolitinib, Fedratinib, and Derivatives Thereof. J.Med.Chem. (2021)

Release Date

2021-01-13

Peptides

Tyrosine-protein kinase JAK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence